Orion Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8K | Hold |
1,500
| – | – | 0.01% | 335 |
|
|
2025
Q1 | $12.9K | Hold |
1,500
| – | – | 0.01% | 341 |
|
|
2024
Q4 | $16.1K | Sell |
1,500
-10,000
| -87% | -$107K | 0.01% | 329 |
|
|
2024
Q3 | $65.3K | Buy |
11,500
+10,000
| +667% | +$56.8K | 0.03% | 126 |
|
|
2024
Q2 | $6.33K | Sell |
1,500
-7,000
| -82% | -$29.5K | ﹤0.01% | 356 |
|
|
2024
Q1 | $43.3K | Hold |
8,500
| – | – | 0.02% | 254 |
|
|
2023
Q4 | $79.1K | Sell |
8,500
-500
| -6% | -$4.66K | 0.05% | 189 |
|
|
2023
Q3 | $59K | Buy |
+9,000
| New | +$59K | 0.04% | 202 |
|
|
2023
Q2 | – | Sell |
-9,500
| Closed | -$81.4K | – | 154 |
|
|
2023
Q1 | $81.4K | Hold |
9,500
| – | – | 0.05% | 173 |
|
|
2022
Q4 | $88K | Hold |
9,500
| – | – | 0.06% | 157 |
|
|
2022
Q3 | $98K | Hold |
9,500
| – | – | 0.08% | 146 |
|
|
2022
Q2 | $95K | Hold |
9,500
| – | – | 0.07% | 151 |
|
|
2022
Q1 | $117K | Hold |
9,500
| – | – | 0.07% | 156 |
|
|
2021
Q4 | $165K | Sell |
9,500
-1,000
| -10% | -$17.4K | 0.09% | 131 |
|
|
2021
Q3 | $188K | Buy |
10,500
+200
| +2% | +$3.58K | 0.11% | 116 |
|
|
2021
Q2 | $235K | Sell |
10,300
-500
| -5% | -$11.4K | 0.15% | 101 |
|
|
2021
Q1 | $161K | Sell |
10,800
-200
| -2% | -$2.98K | 0.11% | 110 |
|
|
2020
Q4 | $59K | Buy |
+11,000
| New | +$59K | 0.04% | 146 |
|